Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 170Neoplasms 129Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Liver Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Dry Eye Syndromes × Clear all
NCT00832130 2011-12-12

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

TearScience, Inc.

Phase NA Completed
139 enrolled 14 charts

Dry Eye Syndromes, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡